Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions
Clinical trial NCT00091689 · COMPLETED
Trial details
- NCT number
- NCT00091689
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2006-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.